Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma

Published:2012-02 Issue:2 Volume:107 Page:253-261
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Kawamura Yusuke,Arase Yasuji,Ikeda Kenji,Seko Yuya,Imai Norihiro,Hosaka Tetsuya,Kobayashi Masahiro,Saitoh Satoshi,Sezaki Hitomi,Akuta Norio,Suzuki Fumitaka,Suzuki Yoshiyuki,Ohmoto Yuki,Amakawa Kazuhisa,Tsuji Hiroshi,Kumada Hiromitsu

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2011327.pdf

Reference50 articles.

1. Rising incidence of hepatocellular carcinoma in the United States.;El-Serag;N Engl J Med,1999

2. Epidemiology of primary liver cancer.;Bosch;Semin Liver Dis,1999

3. Changing incidence of hepatocellular carcinoma in Japan.;Okuda;Cancer Res,1987

4. Cirrhosis and the aetiology of hepatocellular carcinoma.;Johnson;J Hepatol,1987

5. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis.;Ikeda;Hepatology,1993

Cited by 237 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostics and omics technologies for the detection and prediction of metabolic dysfunction-associated steatotic liver disease-related malignancies;Metabolism;2024-12

2. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

3. Insight into the regulatory mechanism of m6A modification: From MAFLD to hepatocellular carcinoma;Biomedicine & Pharmacotherapy;2024-08

4. Risk factors of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: Systematic review and meta-analysis;Technology and Health Care;2024-07-04

5. Modifiable Risk Factors for Hepatocellular Carcinoma in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-Analysis;The American Journal of Medicine;2024-07